Risk factors for postpartum prediabetes and type 2 diabetes in women with gestational diabetes: insights from the edugest study in Argentina.

IF 3 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
J F Elgart, S Salzberg, E Mendez, P Pereyra, N I Gimenez, S Paco Leaños, L A Otiñano Merlo, M A Barrios, I Oliveros, A M Tetta Mirabal, E Sosa, S Rueda, M I Argerich, R A David, C V Farias, S Gorban de Lapertosa
{"title":"Risk factors for postpartum prediabetes and type 2 diabetes in women with gestational diabetes: insights from the edugest study in Argentina.","authors":"J F Elgart, S Salzberg, E Mendez, P Pereyra, N I Gimenez, S Paco Leaños, L A Otiñano Merlo, M A Barrios, I Oliveros, A M Tetta Mirabal, E Sosa, S Rueda, M I Argerich, R A David, C V Farias, S Gorban de Lapertosa","doi":"10.1007/s12020-025-04313-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To describe postpartum glycemic status in a cohort of women with Gestational diabetes (GD) from the EDUGEST (Education in women with GD) study, and to determine factors associated with a diagnosis of prediabetes or T2D.</p><p><strong>Methods: </strong>This observational, analytical study analyzed records of pregnant women with GD recruited in the framework of the EDUGEST study. Data from QUALIDAB-GEST were analyzed for patients who completed postpartum glycemic assessment at six weeks. Information included concurrent cardiovascular risk factors, obstetric history in previous pregnancies, clinical and metabolic indicators, treatments, and postpartum screening results. Descriptive analyses were performed using means ± standard deviation (SD), medians with interquartile ranges [IQR], or proportions, as appropriate. Differences were tested using parametric and non-parametric tests. Regression models assessed factors associated with prediabetes or T2D development postpartum.</p><p><strong>Results: </strong>The analysis included 573 patients (median age: 31 [26-36] years; median gestational age at the first specialty visit after GD diagnosis: 28 [26-32] weeks; BMI: 31.2 [26.7-34.9]). Postpartum screening showed 76.3% normal results, 19.5% prediabetes, and 4.2% T2D. T2D was significantly associated with insulin use during pregnancy (OR: 4.20) and family history of diabetes (OR: 3.21), while prediabetes was associated with hypertension (OR: 2.39), insulin use during pregnancy (OR: 1.62), BMI al the first specialty visit (OR: 1.05), and fructosamine levels (OR: 1.01).</p><p><strong>Conclusion: </strong>This study identified locally relevant parameters associated with postpartum prediabetes and T2D in women with GD, highlighting the importance of early identification of high-risk patients and the role of postpartum glycemic assessment for timely diagnosis.</p>","PeriodicalId":49211,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04313-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To describe postpartum glycemic status in a cohort of women with Gestational diabetes (GD) from the EDUGEST (Education in women with GD) study, and to determine factors associated with a diagnosis of prediabetes or T2D.

Methods: This observational, analytical study analyzed records of pregnant women with GD recruited in the framework of the EDUGEST study. Data from QUALIDAB-GEST were analyzed for patients who completed postpartum glycemic assessment at six weeks. Information included concurrent cardiovascular risk factors, obstetric history in previous pregnancies, clinical and metabolic indicators, treatments, and postpartum screening results. Descriptive analyses were performed using means ± standard deviation (SD), medians with interquartile ranges [IQR], or proportions, as appropriate. Differences were tested using parametric and non-parametric tests. Regression models assessed factors associated with prediabetes or T2D development postpartum.

Results: The analysis included 573 patients (median age: 31 [26-36] years; median gestational age at the first specialty visit after GD diagnosis: 28 [26-32] weeks; BMI: 31.2 [26.7-34.9]). Postpartum screening showed 76.3% normal results, 19.5% prediabetes, and 4.2% T2D. T2D was significantly associated with insulin use during pregnancy (OR: 4.20) and family history of diabetes (OR: 3.21), while prediabetes was associated with hypertension (OR: 2.39), insulin use during pregnancy (OR: 1.62), BMI al the first specialty visit (OR: 1.05), and fructosamine levels (OR: 1.01).

Conclusion: This study identified locally relevant parameters associated with postpartum prediabetes and T2D in women with GD, highlighting the importance of early identification of high-risk patients and the role of postpartum glycemic assessment for timely diagnosis.

妊娠期糖尿病妇女产后前驱糖尿病和2型糖尿病的危险因素:来自阿根廷最大研究的见解
目的:描述来自EDUGEST(妊娠期糖尿病妇女教育)研究的妊娠糖尿病(GD)妇女队列的产后血糖状况,并确定与糖尿病前期或T2D诊断相关的因素。方法:本观察性分析研究分析了在EDUGEST研究框架内招募的妊娠期妊娠妇女的记录。对6周完成产后血糖评估的患者进行QUALIDAB-GEST数据分析。信息包括并发心血管危险因素、以前妊娠的产科史、临床和代谢指标、治疗和产后筛查结果。描述性分析采用均值±标准差(SD)、四分位数区间中位数(IQR)或比例(视情况而定)进行。使用参数检验和非参数检验检验差异。回归模型评估了与产后糖尿病前期或T2D发展相关的因素。结果:纳入573例患者,中位年龄31[26-36]岁;GD诊断后首次专科就诊时的中位胎龄:28[26-32]周;Bmi: 31.2[26.7-34.9])。产后筛查正常76.3%,糖尿病前期19.5%,糖尿病前期4.2%。T2D与妊娠期间胰岛素使用(OR: 4.20)和糖尿病家族史(OR: 3.21)显著相关,而糖尿病前期与高血压(OR: 2.39)、妊娠期间胰岛素使用(OR: 1.62)、首次专科就诊时BMI (OR: 1.05)和果糖胺水平(OR: 1.01)相关。结论:本研究确定了GD女性产后糖尿病前期和T2D的局部相关参数,突出了早期发现高危患者的重要性,以及产后血糖评估对及时诊断的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine
Endocrine ENDOCRINOLOGY & METABOLISM-
CiteScore
6.50
自引率
5.40%
发文量
295
审稿时长
1.5 months
期刊介绍: Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology. Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信